Arvinas (ARVN) Depreciation & Amortization (CF) (2017 - 2026)

Arvinas (ARVN) recorded quarterly Depreciation & Amortization (CF) of $700000.0 in Q1 2026, little changed quarter-over-quarter from $700000.0 in Q4 2025, and little changed on a YoY basis from $700000.0 in Q1 2025.

Arvinas (ARVN) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Arvinas' Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $700000.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) changed 0.0% year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $3.0 million (down 26.83% YoY), while the FY2025 annual figure was $3.0 million, down 34.78% from the prior year.
  • Depreciation & Amortization (CF) was $700000.0 for Q1 2026 at Arvinas, roughly flat from $700000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.7 million in Q4 2022 to a low of $700000.0 in Q1 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $1.1 million across 5 years, with a median of $1.2 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) soared 36.36% in 2022, then slumped 41.67% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.7 million in 2022, then declined by 29.41% to $1.2 million in 2023, then retreated by 8.33% to $1.1 million in 2024, then slumped by 36.36% to $700000.0 in 2025, then changed by 0.0% to $700000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $700000.0 (Q1 2026), $700000.0 (Q4 2025), and $800000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Arvinas 492.16 Mn -122.74 Mn - 700,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 700,000.00
Mar 31, 2026 700,000.00
Dec 31, 2025 700,000.00
Dec 31, 2025 700,000.00
Sep 30, 2025 800,000.00
Sep 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 700,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 1.10 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.10 Mn
Sep 30, 2024 1.10 Mn
Jun 30, 2024 1.20 Mn
Jun 30, 2024 1.20 Mn
Mar 31, 2024 1.20 Mn
Mar 31, 2024 1.20 Mn
Dec 31, 2023 1.20 Mn
Dec 31, 2023 1.20 Mn